Evidence map›Paper›PMID 41094115›Full record

ArticleScientific reports2025

Celiac disease in children with focus on symptoms and quality of life.

Gesala Perez-Junkera, Arrate Lasa, Lissette Delgado-Sanzonetti, Ainara Lekuona Serrano, Maialen Vázquez-Polo, Itziar Churruca, Virginia Navarro, Idoia Larretxi

Registry-linked trialAbstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07436884 (Dieta Sin Gluten Equilibrada y Segura), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07436884 nacompletednot on this map

Dieta Sin Gluten Equilibrada y Segura: Estudio De Biomarcadores y De Los Factores Determinantes Para Alcanzar El Equilibrio Nutricional y La Ausencia de Síntomas

TypeinterventionalSponsorUniversity of the Basque Country (UPV/EHU)Ran2022 to 2025Enrolled71ConditionsCeliac Disease in Children, Nutrition, Healthy, Quality of LifeArmsDietary assesment for children with celiac disease
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gesala Perez-JunkeraGLUTEN3S Research Group, Pharmacy and Food Science Department, University of the Basque Country, Vitoria-Gasteiz, Spain.
Arrate LasaGLUTEN3S Research Group, Pharmacy and Food Science Department, University of the Basque Country, Vitoria-Gasteiz, Spain. arrate.lasa@ehu.eus.
Lissette Delgado-SanzonettiPediatric Gastroenterology, Hospital of Mondragón, Mondragón, Spain.
Ainara Lekuona SerranoPediatric Digestive, Hospital of Zumárraga, Zumarraga, Spain.
Maialen Vázquez-PoloGLUTEN3S Research Group, Pharmacy and Food Science Department, University of the Basque Country, Vitoria-Gasteiz, Spain.
Itziar ChurrucaGLUTEN3S Research Group, Pharmacy and Food Science Department, University of the Basque Country, Vitoria-Gasteiz, Spain.
Virginia NavarroGLUTEN3S Research Group, Pharmacy and Food Science Department, University of the Basque Country, Vitoria-Gasteiz, Spain.
Idoia LarretxiGLUTEN3S Research Group, Pharmacy and Food Science Department, University of the Basque Country, Vitoria-Gasteiz, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The treatment for celiac disease (CD) consist of adhering to a gluten-free diet (GFD). Studies have reported that an appropriate and close nutritional assessment would be beneficial in improving symptoms and quality of life (QoL). This study investigated the effect of a nutritional intervention on the evolution of gastrointestinal (GI) and extraintestinal (EI) symptoms in children newly diagnosed with CD, and its association with QoL. 46 children who had recently been diagnosed with CD were followed up on three occasions during the year: at the time of diagnosis, and after 3 and 12 months (vt0, vt3 and vt12). Participants completed questionnaires on GI- and an EI-symptom, QoL and diet. Recovery was assessed based on clinical improvement and serological response. FODMAP consumption was analysed as a possible cause of symptoms. All patients received dietary advice and face-to-face follow-up. Although following a GFD is beneficial for symptom remission, recovery varies between patients. However, following a GFD is not sufficient to achieve a good QoL, with overall scores suggesting that participants have a poor QoL. Their parents/carers also have this perception. FODMAP consumption cannot be associated with a reduction in symptoms. Follow-up and nutritional education are important for improving GI and EI symptoms. However, more effort is needed to improve QoL in children with CD.

Indexed as

Celiac DiseaseQuality of LifeAdolescentChildChild, PreschoolDiet, Gluten-FreeFemaleHumansMaleSurveys and QuestionnairesCeliac diseaseFODMAPGluten-free dietNutrition interventionQuality of lifeSymptomatology

Identifiers

PMID41094115
PMCPMC12528730

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.